| 发明名称 |
PREVENTION OR TREATMENT AGENT FOR HEPATIC FIBROSIS |
| 摘要 |
In the present invention, a CBP/&bgr;-catenin inhibitor exhibits a superior defibrinating effect with respect to Cre/loxP/HCV-MxCre transgenic mice, which are an experimental animal model for hepatic fibrosis, and is useful as a prevention or treatment drug for hepatic fibrosis. |
| 申请公布号 |
WO2014092154(A1) |
申请公布日期 |
2014.06.19 |
| 申请号 |
WO2013JP83339 |
申请日期 |
2013.12.12 |
| 申请人 |
PRISM PHARMA CO., LTD.;TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE |
发明人 |
ODAGAMI, TAKENAO;KOUJI, HIROYUKI;KOHARA, MICHINORI |
| 分类号 |
A61K45/00;A61K31/5365;A61P1/16;A61P31/14 |
主分类号 |
A61K45/00 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
